Worldwide Demand For Breast Reconstruction Surgery And Treatment Market Will Surge At a CAGR Of 5.9% And Reach US$ 1.61 Billion By 2033

The global Breast Reconstruction Surgery and Treatment Market are anticipated to amass a revenue of US$ 1.61 billion in 2033, rising from an estimated US$ 901.3 million in 2023. The market is set to grow at a moderate and restored CAGR of 5.9% from 2023 to 2033. Historically, the market for breast reconstruction surgery and treatment recorded a CAGR of 4.6% and arrived at a value of US$ 853.9 million in 2022.

An upsurge in the cases of breast cancer, a rise in the number of breast reconstruction procedures, and a growth in the demand for acellular dermal matrix will facilitate the expansion of the breast reconstruction surgery and treatment market in the upcoming years.

Recent developments and improvements in breast reconstruction techniques have enhanced the accuracy of implant positioning while lessening the recovery period and discomfort. This has a positive influence on the breast reconstruction surgery and treatment market. The rising adoption of the acellular dermal matrix (ADMs) will generate greater opportunities than breast implants as a result of the incorporation of advancing technology. This factor will further propel the breast reconstruction surgery and treatment market over the next couple of years.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14393

The high prevalence of breast cancer creates greater demand for breast reconstruction surgery and treatment market as, often, after a mastectomy, many women opt for breast reconstruction surgery. While some women avoid getting breast reconstruction surgery due to either a lack of awareness or other health issues, the number of women who do have the surgery is rising. Thus, growing cases of breast cancer and the rising number of breast reconstruction surgery will bolster the growth of the breast reconstruction surgery and treatment market. Further, the emergence of 3D-printed prosthetics and implants as well as surging research and development efforts in the field will augur well for the development of the breast reconstruction surgery and treatment market.

Key Takeaways:

  • Availability of alternatives like non-surgical methods and a general lack of awareness regarding the treatment options may limit the growth of the breast reconstruction surgery and treatment market.
  • By product, the tissue expanders segment will account for 64.5% of the market share during 2023 and 2033.
  • Based on procedures, the immediate procedure category will dominate the market with a revenue share of 30.1%.
  • The US breast reconstruction surgery and treatment market will likely hold a market share of 32.0% in 2023 owing to the increasing number of breast augmentation operations.
  • China’s breast reconstruction surgery and treatment market will record a CAGR of 3.3% due to the high incidence of breast cancer and a rise in the awareness of treatment options.

Ask the Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-14393

Competitive Landscape 

  • Mentor Worldwide LLC (Johnson & Johnson)
  • Allergan Aesthetics (An AbbVie Company)
  • Sientra
  • POLYTECH Health & Aesthetics GmbH
  • GC Aesthetics
  • Sebbim
  • Establishment Labs S.A.
  • Integra Lifesciences
  • RTI Surgical Holdings
  • Idel Implant Incorporated
  • Laboratoires Arion
  • Silimed
  • Guangzhou Wanhe Plastic Material Co., Ltd.
  • Cereplas
  • Hansbiomed
  • PMT Corporation
  • PFM Medical

Leading market players are focusing on the geographical expansion of business and the launch of new products. These enterprises also employ strategic partnerships, collaborations, mergers, and acquisitions to enhance their market footprints.

Use promo code ->> FMITODAY to get a flat 20% discount

Key Segments Covered in Breast Reconstruction Surgery and Treatment Industry Research

Product:

  • Breast Implants
    • Silicone Implants
    • Saline Implants
  • Tissue Expanders
  • Acellular Dermal Matrix

Procedure:

  • Immediate
  • Delayed
  • Revision

Surgery:

  • Unilateral
  • Bilateral

End-User:

  • Hospitals
  • Cosmetology Clinics and Ambulatory Surgical Centers

Explore Other Reports Links From Healthcare Market:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these